First author
|
Year
|
Country
|
Ethnicity
|
Design
|
Genotyping medthod
|
Number(case/control)
|
SNP
|
HWE
|
---|
Ruan [13]
|
2011
|
China
|
Asian
|
PB
|
TaqMan
|
1334/1568
|
rs2273535
|
0.76
|
Shi [14]
|
2011
|
Sweden
|
Caucasian
|
PB
|
TaqMan
|
763/1516
|
rs2273535
|
0.23
|
MARIE-GENICA [15]
|
2010
|
German
|
Caucasian
|
PB
|
MALDI-TOF
|
3137/5469
|
rs2273535
|
0.12
|
rs1047972
|
0.17
|
Couch [16]
|
2007
|
CIMBA
|
Mixed
|
PB
|
TaqMan
|
3884/3303
|
rs2273535
|
NA
|
Tchatchou [17]
|
2007
|
German
|
Caucasian
|
PB
|
TaqMan
|
727/819
|
rs2273535
|
0.60
|
Vidarsdottir [18]
|
2007
|
Iceland
|
Caucasian
|
NA
|
PCR-RFLP
|
759/653
|
rs2273535
|
0.07
|
Cox [19]
|
2006
|
USA
|
Caucasian
|
NA
|
TaqMan
|
1259/1742
|
rs2273535
|
0.31
|
rs1047972
|
0.70
|
Fletcher [20]
|
2006
|
UK
|
Caucasian
|
PB
|
PCR-RFLP
|
507/875
|
rs2273535
|
0.13
|
Ewart-Toland [21]
|
2005
|
USA
|
Mixed
|
PB
|
SnAPSHOT
|
898/448
|
rs2273535
|
0.81
|
Lo [22]
|
2005
|
China(Taiwan)
|
Asian
|
HB
|
TaqMan
|
709/1972
|
rs2273535
|
0.23
|
rs1047972
|
0.80
|
Dai [23]
|
2004
|
China
|
Asian
|
PB
|
TaqMan
|
1102/1188
|
rs2273535
|
0.07
|
rs1047972
|
0.68
|
Egan [24]
|
2004
|
USA
|
Caucasian
|
PB
|
Sequencing
|
941/830
|
rs2273535
|
0.31
|
rs1047972
|
0.68
|
Sun [25]
|
2004
|
China
|
Asian
|
HB
|
PCR-RFLP
|
520/520
|
rs2273535
|
0.11
|
- HWE: Hardy-Weinberg equilibrium; PB: population based; HB: hospital-based; NA: not available; PCR: polymerase chain reaction; RFLP: restriction fragment length polymorphism; MALDI-TOF MS: Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry; CIMBA: the Consortium of Investigators of Modifiers of BRCA1/2 including 16 clinic and population-based research studies and multicenter consortia.